NasdaqCM - Delayed Quote USD
Aprea Therapeutics, Inc. (APRE)
1.5450
+0.0750
+(5.10%)
At close: April 22 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 16,090 | 4 |
| Sales | 6,462 | 1 |
| Net Shares Purchased (Sold) | 9,628 | 5 |
| Total Insider Shares Held | 650.52k | -- |
| % Net Shares Purchased (Sold) | 1.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GILAD OREN PH.D. Chief Executive Officer | Purchase at price 1.80 - 1.87 per share. | Direct | 10,110 | Apr 3, 2025 |
| HAMILL JOHN P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2025 |
| GILAD OREN PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2025 |
| GILAD OREN PH.D. Chief Executive Officer | Purchase at price 3.92 per share. | Direct | 1,958 | Oct 23, 2024 |
| DUEY MARC Director | Sale at price 4.58 per share. | Direct | 29,583 | Oct 18, 2024 |
| DUEY MARC Director | Purchase at price 3.50 per share. | Direct | 105,000 | Oct 16, 2024 |
| GILAD OREN PH.D. Chief Executive Officer | Purchase at price 2.90 per share. | Direct | 725 | Oct 15, 2024 |
| DUEY MARC Director | Purchase at price 2.58 per share. | Direct | 490 | Oct 14, 2024 |
| GILAD OREN PH.D. Chief Executive Officer | Purchase at price 2.54 - 2.59 per share. | Direct | 2,971 | Oct 14, 2024 |
| HAMILL JOHN P Chief Financial Officer | Purchase at price 2.46 per share. | Direct | 123 | Oct 11, 2024 |
| SEIZINGER BERND R. Director | Purchase at price 2.68 per share. | Direct | 26,800 | Oct 11, 2024 |
| HAMILL JOHN P Chief Financial Officer | Purchase at price 2.61 per share. | Direct | 1,174 | Oct 10, 2024 |
| PAMAKCU RIFAT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| HENNEMAN JOHN BELL III Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| PETERS RICHARD Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| GRISSINGER MICHAEL J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| SEIZINGER BERND R. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| DUEY MARC Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 20, 2024 |
| MIRZA NADEEM Q. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 1, 2024 |
| HAMILL JOHN P Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| GILAD OREN PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| HAMILL JOHN P Chief Financial Officer | Purchase at price 5.55 per share. | Direct | 5,606 | Mar 13, 2024 |
| HENNEMAN JOHN BELL III Director | Purchase at price 5.55 per share. | Direct | 38,073 | Mar 13, 2024 |
| SEIZINGER BERND R. Director | Purchase at price 5.55 per share. | Direct | 38,073 | Mar 13, 2024 |
| GILAD OREN PH.D. Chief Executive Officer | Purchase at price 5.55 per share. | Direct | 11,100 | Mar 13, 2024 |
| PAMAKCU RIFAT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 23, 2023 |
| HENNEMAN JOHN BELL III Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 23, 2023 |
| PETERS RICHARD Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 23, 2023 |
| GRISSINGER MICHAEL J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 23, 2023 |
| SEIZINGER BERND R. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 23, 2023 |
| DUEY MARC Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 23, 2023 |
| SEIZINGER BERND R. Director | Purchase at price 3.63 - 3.68 per share. | Direct | 36,957 | Jun 7, 2023 |
Related Tickers
ANL Adlai Nortye Ltd.
1.9996
-1.50%
IPHA Innate Pharma S.A.
1.9600
+1.55%
2181.HK Mabpharm Limited
0.495
+3.13%
048870.KQ Synergy Innovation Co., Ltd.
2,920.00
-3.15%
ZNTL Zentalis Pharmaceuticals, Inc.
1.4700
+8.09%
ADIL Adial Pharmaceuticals, Inc.
0.6778
+1.33%
ACXP Acurx Pharmaceuticals, Inc.
0.3767
+2.09%
CALC CalciMedica, Inc.
1.5200
-1.30%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1390
0.00%
CALA Calithera Biosciences, Inc.
0.0050
0.00%